Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
08 Mai 2026
Equity research Candles Scandinavia, Q1 2026: A scent of synergies
Equity Research
Candles Scandinavia
08 Mai 2026
Equity Research ALM Equity, Q1 2026: Additional construction starts in 2026
Equity Research
ALM Equity
07 Mai 2026
Equity research Candles, Q1 2026: On track but with margins lagging as the Örebro bet takes shape
Equity Research
Candles Scandinavia
07 Mai 2026
Equity research Viva Wine Group Q1 2026: Organic growth but slightly softer EBITA margin in a slow market
Equity Research
Viva Wine Group
07 Mai 2026
Equity Research ALM Equity Q1 2026: Despite low revenue, there was a positive gross profit
Equity Research
ALM Equity
30 Avr 2026
Equity Research KlaraBo, Q1 2026: A cold quarter, but continued value increases
Equity Research
KlaraBo
29 Avr 2026
Equity research Enrad, Q1 2026: A sluggish start, but the case remains intact
Equity Research
Enrad
29 Avr 2026
Equity Research KlaraBo, Q1 2026: Larger value increases than expected
Equity Research
KlaraBo
29 Avr 2026
Equity research Svenska Aerogel, Q1 2026: Rights issue and focus on upcoming catalysts
Equity Research
Svenska Aerogel
24 Avr 2026
Equity research CDON AB Q1 2026: Building on solid growth momentum
Equity Research
CDON
23 Avr 2026
Equity Research ALM Equity, Q1 2026: Improved market conditions
Equity Research
ALM Equity
23 Avr 2026
Equity research CDON AB: First impression Q1 2026 - Better growth than expected
Equity Research
CDON
20 Avr 2026
Equity Research White Pearl Technology Group, Q1 2026: Revenue beat confirmed, margin quality in focus
Equity Research
White Pearl Technology Group
16 Avr 2026
Equity research Zinzino: Preview Zinzino Q1 2026 - Some moderation of growth
Equity Research
Zinzino
15 Avr 2026
Equity Research KlaraBo, Q1 2026: Improved focus on property management
Equity Research
KlaraBo
15 Avr 2026
Equity research Svenska Aerogel, Q1 2026: Distribution is expanding, but it is still early commercially
Equity Research
Svenska Aerogel
13 Avr 2026
Equity research CDON: Preview Q1 2026 - Continued growth, but initiatives will likely hamper earnings
Equity Research
CDON
13 Avr 2026
Equity research Enrad, Q1 2026: Positive EBITDA in sight, but the real story starts in H2
Equity Research
Enrad
10 Avr 2026
Equity research Viva Wine Group: Preview Q1 2026 - Advancing in sour markets
Equity Research
Viva Wine Group
08 Avr 2026
Equity research, Lokotech H2 2025: Orders stack up and warrants sweeten the case
Equity Research
Lokotech
1
2
3
…
64
